The Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator Initiative Expands Its Focus on Frontotemporal Degeneration
A partnership with The Association for Frontotemporal Degeneration The Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator initiative has announced a new $5 million commitment […]











